Muutke küpsiste eelistusi

Reverse Genetics of RNA Viruses: Applications and Perspectives [Kõva köide]

  • Formaat: Hardback, 408 pages, kõrgus x laius x paksus: 252x177x25 mm, kaal: 767 g
  • Ilmumisaeg: 02-Nov-2012
  • Kirjastus: John Wiley & Sons Inc
  • ISBN-10: 0470979658
  • ISBN-13: 9780470979655
Teised raamatud teemal:
  • Kõva köide
  • Hind: 121,67 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 162,23 €
  • Säästad 25%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 3-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Raamatukogudele
  • Formaat: Hardback, 408 pages, kõrgus x laius x paksus: 252x177x25 mm, kaal: 767 g
  • Ilmumisaeg: 02-Nov-2012
  • Kirjastus: John Wiley & Sons Inc
  • ISBN-10: 0470979658
  • ISBN-13: 9780470979655
Teised raamatud teemal:
For bioscience, medical, and veterinary students, researchers, and academics, Bridgen compiles 12 chapters summarizing recent developments in reverse genetics of RNA viruses through applications in each of the core virus groups, including positive sense, negative sense, and double stranded RNA viruses. Scientists from Europe and the US discuss coronavirus and rhabdovirus reverse genetics, reverse genetic tools to study the hepatitis C virus, calcivirus genetics, modification of the measles virus and application to pathogenesis studies, bunyavirus reverse genetics and applications to studying interactions with host cells, using reverse genetics to improve influenza vaccines, Bluetongue virus reverse genetics, genetic modification in mammalian orthoreoviruses, and reverse genetics and quasispecies. Annotation ©2013 Book News, Inc., Portland, OR (booknews.com)

Reverse genetics, the genetic manipulation of RNA viruses to create a wild-type or modified virus, has led to important advances in our understanding of viral gene function and interaction with host cells. This book provides an account of the developments in reverse genetics of RNA viruses through a range of applications.

Reverse genetics, the genetic manipulation of RNA viruses to create a wild-type or modified virus, has led to important advances in our understanding of viral gene function and interaction with host cells. Since many severe viral human and animal pathogens are RNA viruses, including those responsible for polio, measles, rotaviral diarrhoea and influenza infections, it is also an extremely powerful technique with important potential application for the prevention and control of a range of human and animal viral diseases.

Reverse Genetics of RNA Viruses provides a comprehensive account of the very latest developments in reverse genetics of RNA viruses through a wide range of applications within each of the core virus groups including; positive sense, negative sense and double stranded RNA viruses. Written by a team of international experts in the field, it provides a unique insight into how the field has developed, what problems are being addressed now and where applications may lead in the future. It will prove invaluable to bioscience, medical and veterinary students, those starting research in this area as well as other researchers and teachers needing to update their knowledge of this fast-moving field.

  • An authoritative, comprehensive overview of reverse genetics in RNA Viruses.
  • Includes numerous examples of cutting- edge applications of reverse genetics within each of the RNA viral groups.
  • Written by a team of international experts, including some of the leading researchers in the field.
List of contributors
xi
Acknowledgements xiii
1 Introduction
1(24)
Anne Bridgen
1.1 Background
1(1)
1.2 Reverse genetics for different classes of genome
2(3)
1.3 Methodology
5(6)
1.4 Difficulties in establishing a reverse genetics system
11(2)
1.5 Recent developments
13(1)
1.6 Are there any boundaries for conducting reverse genetics?
13(12)
References
15(10)
Part I Positive sense RNA viruses
25(88)
2 Coronavirus reverse genetics
27(37)
Maria Armesto
Kirsten Bentley
Erica Bickerton
Sarah Keep
Paul Britton
2.1 The Coronavirinae
27(1)
2.2 Infectious bronchitis
28(1)
2.3 Coronavirus genome organisation
29(1)
2.4 The coronavirus replication cycle
30(3)
2.5 Development of reverse genetics system for coronaviruses including IBV
33(4)
2.6 Reverse genetics system for IBV
37(3)
2.7 Reverse genetics systems for the modification of coronavirus genomes
40(9)
2.8 Using coronavirus reverse genetics systems for gene delivery
49(15)
Acknowledgements
51(1)
References
51(13)
3 Reverse genetic tools to study hepatitis C virus
64(27)
Alexander Ploss
3.1 Introduction: hepatitis C
64(1)
3.2 Hepatitis C virus
65(3)
3.3 Construction of infectious clones for hepatitis C virus
68(1)
3.4 Study of HCV RNA replication in cell culture systems
68(2)
3.5 Use of HCV replicons to study viral replication
70(1)
3.6 Utility of replicons for drug screening
71(1)
3.7 Development of the infectious cell culture systems for HCV
71(1)
3.8 Construction of intergenotypic viral chimeras
72(2)
3.9 Non-JFH1 derived genomes
74(1)
3.10 Cell lines that support HCV replication
74(1)
3.11 Study of HCV in physiologically more relevant cell culture systems
75(1)
3.12 Animal models for HCV infection
76(1)
3.13 Reverse genetics of clinically relevant HCV genotypes in vivo
77(1)
3.14 Conclusion
78(13)
Acknowledgments
78(1)
References
78(13)
4 Calicivirus reverse genetics
91(22)
Ian Goodfellow
4.1 Introduction
91(2)
4.2 Feline calicivirus
93(4)
4.3 Murine norovirus
97(6)
4.4 Porcine enteric calicivirus
103(1)
4.5 Rabbit haemorrhagic disease virus
104(1)
4.6 Human norovirus
104(2)
4.7 Conclusion
106(7)
Acknowledgements
107(1)
References
107(6)
Part II Negative sense RNA viruses
113(138)
5 Reverse genetics of rhabdoviruses
115(35)
Alexander Ghanem
Karl-Klaus Conzelmann
5.1 Introduction: the Rhabdoviridae family
115(6)
5.2 Rhabdovirus reverse genetics
121(11)
5.3 Applications and examples
132(5)
5.4 Conclusion
137(13)
Acknowledgements
137(1)
References
137(13)
6 Modification of measles virus and application to pathogenesis studies
150(50)
Linda J. Rennick
W. Paul Duprex
6.1 Introduction
150(1)
6.2 Measles: the disease
150(1)
6.3 Measles: the infectious agent
151(3)
6.4 RNA synthesis: a tail of two processes
154(1)
6.5 Transcription: starting, stopping, dropping off or starting again
154(1)
6.6 From transcription to replication: the elusive switch
155(2)
6.7 Getting in and getting out
157(1)
6.8 Measles virus: reverse genetics
158(23)
6.9 Future perspectives
181(19)
Acknowledgements
182(1)
References
182(18)
7 Bunyavirus reverse genetics and applications to studying interactions with host cells
200(24)
Richard M. Elliott
7.1 Introduction: the family Bunyaviridae
200(1)
7.2 Bunyavirus replication
201(2)
7.3 History of bunyavirus reverse genetics
203(2)
7.4 Minigenome systems for bunyaviruses
205(2)
7.5 Virus-like particle production
207(1)
7.6 Rescue systems for bunyaviruses
208(1)
7.7 Application of reverse genetics to study bunyavirus replication
208(7)
7.8 Outlook
215(9)
References
216(8)
8 Using reverse genetics to improve influenza vaccines
224(27)
Ruth A. Elderfield
Lorian C.S. Hartgroves
Wendy S. Barclay
8.1 Introduction
224(3)
8.2 Influenza vaccines
227(2)
8.3 The use of reverse genetics to generate recombinant influenza A, B and C viruses
229(3)
8.4 Using reverse genetics technology for generation of pandemic virus vaccine
232(3)
8.5 Other strategies for generating live attenuated vaccines based on viruses engineered by reverse genetics
235(3)
8.6 Strategies to improve the safety or yield of influenza vaccines
238(1)
8.7 Improvements to the PR8 high growth strain
239(1)
8.8 Improving the immunogenicity by engineering recombinant viruses that express cytokine genes
240(1)
8.9 Novel species-specific attenuation that takes advantage of microRNAs
240(1)
8.10 Conclusion
241(10)
References
241(10)
Part III Double-stranded RNA viruses
251(68)
9 Bluetongue virus reverse genetics
253(36)
Mark Boyce
9.1 Introduction to Bluetongue virus
253(1)
9.2 Bluetongue virus replication
254(6)
9.3 Reverse genetics
260(11)
9.4 Uses of reverse genetics in orbivirus research
271(7)
9.5 Future perspectives
278(11)
References
281(8)
10 Genetic modification in mammalian orthoreoviruses
289(30)
Sanne K. van den Hengel
Iris J.C. Dautzenberg
Diana J.M. van den Wollenberg
Peter A.E. Sillevis Smitt
Rob C. Hoeben
10.1 Introduction
289(7)
10.2 Forward-genetics in orthoreoviruses
296(1)
10.3 Reovirus/cell interactions
297(4)
10.4 Reverse-genetics in orthoreoviruses
301(5)
10.5 Reovirus as an oncolytic agent
306(2)
10.6 Conclusion
308(11)
References
309(10)
Part IV Recent and future developments
319(56)
11 Reverse genetics and quasispecies
321(29)
Antonio V. Borderia
Marco Vignuzzi
11.1 Definition of quasispecies and evidence
321(7)
11.2 Reverse genetics and RNA virus population heterogeneity: consensus is always a compromise
328(5)
11.3 Examples of the use of the theory to disable or manipulate the quasispecies under controlled environments
333(6)
11.4 Future prospects of virus population genetics and reverse genetics
339(2)
11.5 Conclusion
341(9)
References
342(8)
12 Summary and perspectives
350(25)
Anne Bridgen
12.1 Introduction
350(1)
12.2 Analysis of the role of specific non-coding sequence motifs involved in replication, transcription, polyadenylation and packaging
351(1)
12.3 Analysis of the roles of viral proteins
352(1)
12.4 Analysis of virus-host interactions at a global level
353(1)
12.5 Understanding the basis of pathogenicity
354(1)
12.6 Real-time virus imaging in vitro and in vivo
355(1)
12.7 Structure-function analysis of viruses and viral domains
356(1)
12.8 Vaccine generation
357(2)
12.9 Drug development
359(2)
12.10 Gene delivery and knock-out in plant cells including virus-induced gene silencing (VIGS)
361(1)
12.11 Gene delivery in arthropod and mammalian cells
362(1)
12.12 Development of oncolytic virus and adaptation to this purpose
363(1)
12.13 Personal highlights and future directions
364(11)
References
366(9)
Index 375
Dr Anne Bridgen, previously of The University of Ulster is a molecular virologist with extensive research and teaching experience. She was the first scientist to recover infectious virus particles from DNA clones of a segmented RNA virus. Dr Bridgen knows the field and its main players well and has both the knowledge and experience to bring individual expert contributions together around the common theme of reverse genetics. She is currently providing consultancy for a BBSRC grant based at IAH Pirbright.